rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
16
|
pubmed:dateCreated |
2009-9-1
|
pubmed:databankReference |
|
pubmed:abstractText |
Standardized treatment (24-week) with pegylated interferon and ribavirin induces sustained virological response in 80 % of patients with Hepatitis C (HCV) genotype 2 or 3. Most patients who are dependent on heroin and receiving methadone maintenance therapy (MMT) have been excluded from this treatment due to concerns about compliance. Short-term therapy (14 weeks) of other patient groups have shown promising results. The purpose of this study was to investigate the feasibility, efficacy and adverse effects of short-term treatment in a group of MMT patients with chronic hepatitis C infection genotype 3.
|
pubmed:language |
nor
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0807-7096
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
27
|
pubmed:volume |
129
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1639-42
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:19721480-Adult,
pubmed-meshheading:19721480-Antiviral Agents,
pubmed-meshheading:19721480-Female,
pubmed-meshheading:19721480-Genotype,
pubmed-meshheading:19721480-Hepacivirus,
pubmed-meshheading:19721480-Hepatitis C, Chronic,
pubmed-meshheading:19721480-Heroin Dependence,
pubmed-meshheading:19721480-Humans,
pubmed-meshheading:19721480-Interferon-alpha,
pubmed-meshheading:19721480-Male,
pubmed-meshheading:19721480-Patient Care Team,
pubmed-meshheading:19721480-Polyethylene Glycols,
pubmed-meshheading:19721480-Prospective Studies,
pubmed-meshheading:19721480-Recombinant Proteins,
pubmed-meshheading:19721480-Ribavirin,
pubmed-meshheading:19721480-Substance Abuse, Intravenous,
pubmed-meshheading:19721480-Time Factors,
pubmed-meshheading:19721480-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
[Short-term treatment of Hepatitis C in heroin-dependent patients].
|
pubmed:affiliation |
Avdeling for rus- og avhengighetsbehandling, Sørlandet sykehus, 4604 Kristiansand, Norway. oistein.kristensen@sshf.no
|
pubmed:publicationType |
Journal Article,
English Abstract
|